جست‌وجوی استاد و پژوهشگر

Troels Kasper Høyer Scheelمشاهده پروفایل

دانشیار

• Virology
• RNA viruses
• Molecular biology of viral infections
• +۷ مورد دیگر

Troels Kasper Høyer Scheel is a Tenured Associate Professor at the Department of Immunology and Microbiology, University of Copenhagen, and the Copenhagen Hepatitis C Program (CO-HEP). He is also a Guest Investigator at the Laboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University in New York. His research group, consisting of around 10 researchers, investigates virus-host interactions at the molecular level, with a particular focus on RNA viruses and their interplay with cellular factors at the RNA level. His educational background includes: PhD in Virology (2011) from CO-HEP, Dept. of Infectious Diseases, Hvidovre Hospital and Dept. of Immunology and Microbiology, University of Copenhagen MSc in Biochemistry (2007) from University of Copenhagen BSc in Biochemistry (2004) from University of Copenhagen Dr. Scheel's research focuses on the molecular and cellular biology of viral infections, particularly studying RNA viruses including HCV, pestiviruses, equine hepacivirus, and rodent hepacivirus. His group has made significant contributions to understanding how viruses interact with cellular miRNAs, with groundbreaking work showing that HCV requires miR-122 for replication and that pestiviruses similarly require miR-17 family members. His work spans miRNA systems biology, RNA modifications, development of in vivo infectious clones, and molecular evolution of RNA viruses. His recent publications demonstrate a strong focus on HCV models, viral evolution, and host-pathogen interactions. His work spans basic virology, molecular biology, and translational research with implications for therapeutic development, particularly in understanding viral mechanisms that could inform vaccine development and antiviral therapies. His scientific awards include: Carlsberg Foundation Young Researcher Fellowship (2021) Starting Grant from the European Research Council (2018) Starting Grant from The Danish Council for Independent Research (2016) Sapere Aude: Research Talent Award from The Danish Council For Independent Research (2011) Dr. Scheel teaches courses on 'The Immune Response to Infection' for the Immunology and Inflammation MSc program, and delivers lectures on virology for Human Biology and Medicine programs. He leads research projects funded by multiple prestigious grants and collaborates with approximately 40 scientists within the Copenhagen Hepatitis C Program. His laboratory is located on the 13th floor at the Panum Institute in Copenhagen, where he continues to investigate novel aspects of virus-host interactions that have implications for understanding viral pathogenesis and developing new therapeutic approaches.

Faidon Magkosمشاهده پروفایل

استاد

• Metabolism
• Diet
• Exercise
• +۷ مورد دیگر

Faidon Magkos is a Professor in Obesity and Metabolism at the Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark, and holds an honorary professorship at University College London's Faculty of Medical Sciences. With over 244 research outputs including 148 original research articles, he has established himself as a leading researcher in human metabolism, diet, and exercise science. Magkos earned his B.Sc. in Human Nutrition & Clinical Dietetics (2000), M.Sc. in Nutrition and Exercise (2004), and Ph.D. in Human Metabolism (2008). His academic journey includes postdoctoral positions at Harokopio University and Harvard Medical School, followed by faculty appointments at Washington University School of Medicine, National University of Singapore, and ultimately the University of Copenhagen. His research focuses on human metabolism, particularly examining how diet and exercise affect health and disease. He employs sophisticated methodologies including glucose tolerance tests, hyperinsulinemic-euglycemic clamps, DXA, MRI, MRS, tissue biopsies, and indirect calorimetry to investigate energy and substrate metabolism, lipid kinetics, and insulin sensitivity across different tissues. His recent publications (2023-2025) demonstrate a strong focus on obesity, metabolic health, pregnancy nutrition, liver fat, and dietary interventions. His work spans clinical trials, hypothesis development, and systematic reviews, with particular attention to high-protein diets, glycemic index, and metabolic adaptations. World's Top 2% Most-Cited Scientists (career-long, top 0.9%) World's Top 2% Most-Cited Scientists (2023, top 0.2%) Google Scholar h-index=67; i10-index=176 Web of Science h-index=51; Scopus h-index=55 Magkos has secured substantial research funding totaling €37,142,381, with €8,462,007 as PI/Co-PI. He serves on editorial boards including the American Journal of Clinical Nutrition and as Associate Editor for Clinical Nutrition and Frontiers in Nutrition. His research has been supported by major organizations including AHA, NIH/NIDDK, A*STAR, NMRC, NNF, DFF, Nestle, and Arla. He leads a research program investigating the mechanisms by which diet and exercise alter physiological function, with particular interest in obesity, diabetes, and metabolic disorders. His work bridges basic science with clinical applications, creating a comprehensive understanding of human metabolism.

• Liver Regeneration
• Stem Cell Differentiation
• Hepatic Programming
• +۳ مورد دیگر

Hanne Cathrine Bisgaard is an Associate Professor at the Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen. Her research focuses on cellular and molecular mechanisms involved in foetal and adult programming of the mammalian liver, with specific emphasis on stem/progenitor cell differentiation into hepatocytes and cholangiocytes. She also administers the 'Chemical Components of the Cell' course for medical and odontology students. Education: M.Sc. in Biochemistry (1985) Ph.D. (Lic.Scient) in Microbiology, University of Copenhagen, Denmark (1990) Research Interests: Dr. Bisgaard's primary research investigates the characterization of cellular and molecular mechanisms in liver development and regeneration. Her work includes in vitro programming and differentiation of human hepatic progenitor cells, human embryonic stem cells, and induced pluripotent stem cells along hepatic cell lineages. She specifically examines nutritional effects of the microenvironment on differentiation processes and identifies novel molecular mechanisms involved in repair and regeneration of injured liver using experimental animal models in mouse and rat. Current investigations focus on hexose-induced changes in mitochondrial phenotype during liver cell differentiation and developing in vitro systems for studying hepatic differentiation and associated diseases using induced pluripotent stem cells and gene editing. Scientific Awards: Fogarty International Postdoctoral Fellowship, National Institutes of Health, USA (1990-1994) Fellowships from the Danish Cancer Society (1992-1993 and 1994-1995) Fellowship from the Danish Research Academy (1989-1990) Advising and Grants: Dr. Bisgaard has supervised 2 post docs, 12 Ph.D. students, and 14 master students since 1995. She serves as a referee for grant agencies including Welcome Trust, Hungarian Scientific Research Fund (OTKA), and The Danish Multiple Sclerosis Society. Her research has been supported by various fellowships and grants throughout her career. Laboratory and Collaborations: Dr. Bisgaard's laboratory collaborates with researchers including Bjørn Quistorff (Department of Biomedical Sciences), Lene Juel Rasmussen (Center for Healthy Aging), Lisbeth Birk Møller (Medical Genetics Laboratory), and international collaborators like Peter Nagy at Semmelweis University in Budapest. She is actively involved in the Morphogenesis and Differentiation Program at the Department of Cellular and Molecular Medicine.

• Infectious Diseases
• Virology
• HIV
• +۳ مورد دیگر

Nina Weis is a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen, Denmark, with dual institutional affiliation at the Capital Region of Denmark (Region Hovedstaden) as confirmed by her regionh.dk email domain and office addresses in Hvidovre and Copenhagen N. Her research specializes in clinical infectious diseases with emphasis on HIV, hepatitis viruses, and bacteriology. Her research program integrates clinical medicine with public health approaches, investigating antiviral treatment efficacy, viral evolution mechanisms, diagnostic innovations like dried blood spot testing, and psychosocial dimensions of infection. She frequently employs Danish nationwide registry data and cross-sectional designs to study infection outcomes in vulnerable populations including pregnant women, cardiac surgery patients, and harm reduction service users. Analysis of her 2025 publications reveals dominant themes in viral hepatitis management and HIV care optimization. Key trends include immune response characterization post-hepatitis C cure, stigma impacts on HIV health outcomes, metabolic effects of novel antiretroviral regimens, and community-based HCV testing strategies. Her work consistently demonstrates multi-institutional Danish collaborations addressing critical gaps in infection control and patient-centered care.

• Nutrition Science
• Obesity Research
• Prenatal Nutrition
• +۴ مورد دیگر

Nina Rica Wium Geiker serves as a Guest Researcher at the Department of Nutrition, Exercise and Sports (NEXS) within the Faculty of Science at the University of Copenhagen. Her research is centered in the Lifecourse Nutrition & Health group, where she investigates critical intersections between nutrition, metabolism, and health outcomes across different life stages. Her research interests focus on prenatal nutrition interventions, particularly examining how maternal dietary patterns during pregnancy affect offspring growth trajectories and metabolic health. She has substantial expertise in body composition analysis, with numerous studies investigating adipose tissue distribution during pregnancy and its implications for maternal and child health outcomes. Her work frequently addresses obesity-related issues across the lifespan, from childhood interventions for socially vulnerable populations to metabolic consequences of fat distribution in adults. Dr. Geiker's recent publications demonstrate a strong emphasis on clinical nutrition research, with multiple randomized controlled trials and longitudinal studies examining dietary interventions during pregnancy, particularly for women with overweight or obesity. Her methodological expertise includes validation of dietary assessment tools and advanced body composition analysis using imaging techniques. She has secured research funding from diverse sources including the Novo Nordisk Foundation, Danish Pig Meat Association, Danish Dairy Research Foundation, Nordea Foundation, Arla Food for Health, and several other industry and charitable organizations focused on nutrition and health.

Jannick Prentøمشاهده پروفایل

دانشیار

• Virology
• Hepatitis C research
• Immune evasion
• +۷ مورد دیگر

Jannick Prentø is an Associate Professor at the University of Copenhagen's Faculty of Health and Medical Sciences, holding joint appointments in the Department of Immunology and Microbiology (Virology section) and the Department of Biomedical Sciences (Endocrinology and Metabolism section). His research focuses on structural virology with an emphasis on hepatitis C virus (HCV) mechanisms and vaccine development. Dr. Prentø's primary research interests include the structural basis of HCV immune evasion, particularly focusing on the E2 glycoprotein and hypervariable region 1 (HVR1). His laboratory employs an integrated approach combining wet lab techniques , in silico modeling , cryo-EM , and molecular dynamics simulations to study viral entry mechanisms and neutralization. His team has made significant contributions to understanding the HCV envelope protein complex structure, recently discovering it forms an antiparallel homodimer of E1 and E2 proteins. Analysis of Dr. Prentø's publication record reveals a strong focus on HCV structural biology, immune evasion mechanisms, and vaccine development. His recent work (2022-2025) demonstrates increasing emphasis on translating structural insights into practical vaccine candidates, with multiple studies on inactivated HCV vaccines that induce broadly neutralizing antibodies. His research bridges basic structural virology with translational applications, particularly in developing cross-genotype protective immunity. As an educator, Dr. Prentø teaches virology laboratory courses for medical students and organizes a Ph.D. course on preclinical and clinical aspects of vaccine development. He has also served as a mentor in the SUND postdoc mentor program in 2022 and 2023. His laboratory specializes in integrating structural methodologies with functional viral studies, particularly focusing on how HCV's structural features enable it to switch between neutralization-sensitive and neutralization-resistant states. This work has significant implications for developing effective HCV vaccines and understanding fundamental mechanisms of viral immune evasion.

• Chronic Liver Disease
• Cirrhosis
• Portal Hypertension
• +۵ مورد دیگر

Søren Møller serves as Clinical Professor at the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at University of Copenhagen. He concurrently holds position as Chief Physician and Specialist in Clinical Physiology and Nuclear Medicine at Hvidovre Hospital, maintaining dual academic-clinical appointment. His extensive research portfolio spans over 210 publications focusing on hemodynamic and homeostatic pathophysiology in chronic liver diseases. Professor Møller's research interests center on chronic liver disease complications including portal hypertension, cirrhotic cardiomyopathy, hepatorenal syndrome, and hepatopulmonary syndrome. His laboratory investigates biomarkers (NGAL, hsTNT, hsCRP, sUPAR) and conducts clinical trials on betablockers, rifaximin, and vasoconstrictors. Current programs examine bacterial translocation effects, pulmonary function changes, and intrahepatic shunt impacts through TIPS procedures. His work bridges basic pathophysiological mechanisms with translational clinical applications. Recent publication analysis reveals strong focus on metabolic dysfunction-associated steatotic liver disease (MASLD), advanced imaging techniques for hemodynamic assessment, and non-invasive diagnostic proteomics. His research increasingly incorporates multi-omics approaches and population-based cohort studies, with significant emphasis on cardiovascular complications in liver disease and metabolic cross-talk between organs. The 2025 publications demonstrate methodological diversity spanning clinical trials, molecular analysis, imaging studies, and epidemiological investigations. Professor Møller actively collaborates with Rigshospitalet and maintains extensive international research networks. His laboratory conducts both acute hemodynamic protocols and long-term outcome studies, with particular emphasis on fluid retention mechanisms and organ-specific complications in cirrhosis. Current projects include investigating dobutamine effects on cardiac function in advanced cirrhosis and developing novel biomarkers for renal injury prediction.

• Microcirculation
• Vascular Adaptation
• Flow Regulation
• +۵ مورد دیگر

Jens Christian Brings Jacobsen is an Associate Professor at the Department of Biomedical Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen, where he leads research in the Renal and Vascular Research group. His work focuses on computational models of microcirculation and vascular dynamics, addressing fundamental questions about the relationship between blood vessel structure and function. His primary research interests include: Computer models of microvessels Structural adaptation in vascular networks Simulation of individual vascular cells and groups of cells Microcirculation and arterial blood pressure interactions Dr. Jacobsen's research examines how blood pressure influences the structure of the smallest blood vessels and how the microcirculation affects arterial blood pressure. His work also investigates how the body ensures that microcirculation can continuously meet changing tissue needs through models of flow regulation, vascular networks, the myogenic response, vascular conducted responses, intracellular calcium dynamics, vasomotion, and synchronization. His research spans multiple disciplines including physiology, computational biology, and medical engineering. His recent publications demonstrate expertise across multiple domains including endocrinology, metabolism, cardiology, nephrology, gerontology, and vascular physiology. His work typically involves collaborative research with international teams across multiple institutions, reflecting the interdisciplinary nature of his research questions. Scientific contributions: Current supervisor for 2 PhD students Reviewer for 8 different journals Member of study board for Health Informatics at University of Copenhagen Extensive teaching experience in physiological modeling and related subjects Dr. Jacobsen maintains an active research program with numerous collaborations across different countries and institutions, as evidenced by his extensive publication record, conference presentations, and research outputs. His work continues to advance our understanding of microvascular physiology and its implications for human health and disease.

• Animal Science
• Veterinary Science
• Nutrition
• +۳ مورد دیگر

Christina Larsen serves as an Assistant Professor in the Department of Veterinary and Animal Sciences at the University of Copenhagen, with dual affiliations in the Comparative Pediatrics and Nutrition and Animal Welfare and Disease Control research groups. Her work focuses on optimizing swine production systems through evidence-based interventions targeting piglet development and health. Her research portfolio emphasizes: Animal Nutrition and Feed Additive Efficacy Gut Microbiome Dynamics and Health Immune System Maturation in Neonates Weaning Strategies and Transition Management Swine Production Efficiency Metrics Microbiota-Based Disease Prevention Analysis of her 11 publications (2023-2025) reveals a concentrated research trajectory on nutritional and microbial interventions for pre-weaning piglets. Key thematic clusters include benzoic acid supplementation for intestinal integrity, lactose-enhanced creep feeding protocols, microbiota transplantation techniques, and weaning age optimization – all converging on reducing post-weaning diarrhea while enhancing growth metrics through molecular and physiological mechanisms. Collaboration patterns indicate strong interdisciplinary networks across veterinary medicine, animal nutrition, and molecular biology, with frequent co-authorship on studies integrating genomic, immunological, and production data from controlled swine trials.

Jens Bukhمشاهده پروفایل

استاد

• Hepatitis C
• Virology
• Vaccine Development
• +۵ مورد دیگر

Jens Bukh is a Professor in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Virology. His research is centered around the Copenhagen Hepatitis C Program (CO-HEP), focusing on basic studies of the hepatitis C virus life cycle with important clinical implications for developing better therapies and vaccines that address the global health burden affecting over 150 million people worldwide. Professor Bukh's research spans hepatitis C virus pathogenesis, viral evolution, antibody responses, and vaccine development. His work examines how hepatitis C virus evolves within hosts under immune pressure, particularly focusing on the hypervariable region 1 and its role in antibody evasion. He has expanded his research to include related hepaciviruses like the Norway rat hepacivirus as model systems, and more recently into SARS-CoV-2 cellular mechanisms. His laboratory investigates molecular mechanisms of viral persistence with the goal of informing therapeutic and vaccine development. Analysis of Professor Bukh's recent publications reveals a strong focus on viral immunity and evolution. His research examines cross-reactive neutralization, T cell responses, and viral escape mechanisms. He employs both in vitro and in vivo model systems, with significant work on the Norway rat hepacivirus as a valuable model for understanding hepatitis C virus biology. His collaborative work spans multiple institutions and leverages advanced techniques in virology and immunology. Professor Bukh leads the Copenhagen Hepatitis C Program (CO-HEP), which conducts fundamental research with direct clinical applications. His laboratory maintains active collaborations with clinical researchers and utilizes both human samples and animal models to advance understanding of hepacivirus biology. The program aims to contribute directly to the global effort to combat hepatitis C through improved understanding of viral pathogenesis and the development of more effective therapeutic and preventive strategies.

• Metabolism
• Endocrinology
• Diabetes Research
• +۳ مورد دیگر

Stephanie Kjærulff Holm serves as a Research Fellow in the Clemmensen Group at the Faculty of Health and Medical Sciences, University of Copenhagen. Her primary research focus centers on metabolic regulation, particularly investigating LEAP2 (Liver-Expressed Antimicrobial Peptide 2) and its interactions with key metabolic hormones. Dr. Holm's research program examines how metabolic states and interventions influence hormone signaling pathways related to appetite and weight control. Her work spans multiple experimental approaches, including mouse models of metabolism, human clinical studies, and molecular analyses of hormone production. She has made significant contributions to understanding how insulin, glucagon, ketone bodies, and dietary components regulate LEAP2 function and how these mechanisms relate to metabolic disorders. Analysis of her publication record from 2022-2025 reveals a cohesive research trajectory focused on the intersection of nutrition, pharmacology, and endocrine signaling in metabolic regulation. Her work frequently examines LEAP2 in relation to established metabolic pathways including GDF15-GFRAL signaling and incretin hormone systems, with implications for obesity and diabetes therapeutics. Dr. Holm maintains an active collaborative network within the metabolic research community, working with prominent researchers in the field including Clemmensen, Holst, and Knop. Her research has been published in high-impact journals such as Cell Reports Medicine, Diabetes, and Molecular Metabolism, demonstrating both scientific rigor and clinical relevance.

• Gastroenterology
• Hepatology
• Liver Diseases
• +۳ مورد دیگر

Martin Eefsen serves as a Clinical Associate Professor at the Department of Clinical Medicine within the Faculty of Health and Medical Sciences, University of Copenhagen. His clinical specialization focuses on Gastroenterology and Hepatology at the Internal Medicine division, with contact details including phone +4538635158 and email martin.eefsen@regionh.dk. His research program investigates critical intersections between liver pathology and neurological complications, particularly hyperammonemia-induced intracranial hypertension and acetaminophen toxicity mechanisms. Key interests include molecular pathways in ammonia neurotoxicity, genetic determinants of drug-induced liver injury, and translational applications of animal models to human disease. This work bridges clinical hepatology with basic science through rat model systems and patient cohort analyses. Publication trends reveal consistent focus on hepatic encephalopathy pathophysiology and pharmacogenetics, with recent work examining ciclosporin interventions, NKCC1 transporter dynamics, and glutathione S-transferase polymorphisms. These studies contribute to understanding liver failure complications and optimizing toxicology management protocols. No scientific awards were documented in the provided materials. Information regarding student supervision and grant funding remains unspecified, though collaborative research patterns are evident through multi-author publications. Dr. Eefsen operates within the Department of Clinical Medicine's research infrastructure at Blegdamsvej 3, Copenhagen, maintaining strong ties between University of Copenhagen academic activities and Region Hospital clinical practice in gastroenterology services.

• Inflammatory Bowel Disease
• Gastroenterology
• Epidemiology
• +۵ مورد دیگر

Johan Michael Burisch serves as a Clinical Professor at the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen, holding a dual appointment with the Capital Region of Denmark. He is also a chief physician at Amager and Hvidovre Hospital's Gastrounit and holds the title of Doctor of Medical Sciences (dr.med.). Dr. Burisch's research program centers on inflammatory bowel diseases (IBD), where he integrates epidemiology, multi-omics approaches, and individualized treatment strategies. His work includes leading large-scale studies like the ECCO-EpiCom project to explore global and regional differences in IBD incidence and prevalence. He combines genetic, microbiome, and proteomic data to identify molecular subgroups of IBD, improving disease prognosis and advancing personalized treatment approaches. His research also investigates IBD natural history, complications including colorectal cancer, and develops predictive tools to enhance patient outcomes through multidisciplinary care models and eHealth solutions. Analysis of his recent publications reveals a strong focus on dietary quality in IBD patients, cancer risks in polyposis syndromes, biomarkers for disease monitoring, anti-TNF treatment outcomes, novel drug formulations for ulcerative colitis, and evidence-based clinical guidelines. These works span multiple disciplines including gastroenterology, epidemiology, biomarker research, clinical trial design, and healthcare economics. UEG National Scholar Award (Best from Denmark) (2012, 2017) ECCO Presidential Price for young investigators (2013) The Lundbeck Foundation's Talent Price (2014) Jakobinerklubbens hædersmedajle (2014) ECCO Mark of Merit (2016) UEG Rising star award (2019) ECCO Young Researcher Award – Clinical/translational science (2023) Erhoff Fondens Talentpris (2024) Dr. Burisch currently supervises 5 medical students and 7 PhD students. His research program is supported by substantial funding including AbbVie (1.2 million €), Takeda Pharma (400,000 €), and Novo Nordisk Foundation (8 million € for a Challenge grant). He leads multiple major research initiatives including the Danish Inflammatory bowel disease Biobank (DIB), EPI-IBD, and The INCEPTION study. As an associate editor for the Journal of Crohn's and Colitis and editorial board member for Gut and Alimentary Pharmaceuticals and Therapeutics, he plays a significant role in shaping the scientific discourse in his field. He is actively involved in professional organizations including the European Crohn's & Colitis Organization (Guideline Committee 2024-2027) and United European Gastroenterology.

Henrik Clausenمشاهده پروفایل

استاد

• Glycomics
• Glycobiology
• Cancer Biomarkers
• +۵ مورد دیگر

Henrik Clausen is a Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. He leads the Copenhagen Center for Glycomics and is actively engaged in developing innovative technologies to advance the field of glycomics. His work focuses on transforming glycosciences from a specialist field into a mainstream 'Omics' discipline comparable to genomics and proteomics. Dr. Clausen earned his DDS in 1981 and Dr.odont (D.Sc.) in 1990, both from the School of Dentistry, Faculty of Health Sciences at the University of Copenhagen. His academic journey includes positions at the University of Washington in Seattle and the Biomembrane Institute, before returning to Copenhagen where he became Professor at the Institute of Cellular and Molecular Medicine in 2005. His primary research focuses on glycans that coat proteins in nature, with particular expertise in blood type conversion (transforming blood types A, B, and AB to blood type O) and cancer biomarkers. Through projects like GlycoDisplay, GlycoCRISPR, GlycoDesign, and GlycoView, his laboratory develops tools and community resources to make glycoscience more accessible to non-specialists. His current research includes a Lundbeck Foundation-funded program (2017-19) to develop a cell-based platform displaying all human glycans for high-throughput screening. Analysis of his recent publications reveals a strong focus on glycan-protein interactions, particularly in cancer and infectious disease contexts. His work spans structural biology, enzymology, and cell signaling, with applications in immunology, virology, and oncology. The research demonstrates how glycosylation affects receptor function, cell signaling, and pathogen-host interactions, with significant implications for therapeutic development. The Benzow Prize (1994) The Thureus Prize (1998) Mizutani Prize (1999) The Carlsberg Biotechnology Prize (2008) Professor Clausen serves on the editorial boards of Glycoconjugate Journal (since 1995) and Journal of Biological Chemistry (since 2004). He has organized numerous international conferences including Benzon Symposia, Nordic Glycobiology Symposia, and International Glycosyltransferase Symposia. His industry collaborations include advisory roles at Aptein Inc, Neose Inc, ZymeQuest Inc, and Millennium Pharmaceuticals. He directs the Copenhagen Center for Glycomics, which develops extensive glycopeptide libraries representing cancer-associated glycoforms of membrane glycoproteins. These libraries are printed on microarray slides to detect antibodies against cancer antigens in patient samples, with the goal of identifying autoantibody signatures as sensitive and specific cancer markers.

Jesper Bøje Andersenمشاهده پروفایل

استاد

• Immunogenomics
• Metabolism
• Epigenomic remodeling
• +۷ مورد دیگر

Professor Jesper Bøje Andersen is a Professor in Translational Hepatology at the University of Copenhagen, based at the Biotech Research and Innovation Centre (BRIC) within the Faculty of Health and Medical Sciences. He leads the Andersen Group, which focuses on utilizing genome-wide approaches to model disease causality and develop diagnostic, prognostic, and therapeutic strategies for hepatobiliary cancers. Education: PhD in Translational Genomics and Epigenomics from Aarhus University, Denmark (2006) Joint research fellowship at University of Maryland, Department of Medicine, Marlene and Stewart Greenebaum Cancer Center, Baltimore, USA (2003-2007) Professor Andersen's research centers on three main themes: Immunogenomics, metabolism, and epigenomic remodeling in the context of hepatobiliary cancers. His work aims to significantly guide novel treatment modalities and impact clinical practice to improve patient outcomes. The Andersen Group employs cutting-edge technologies including single-cell genomics, tumor heterogeneity analysis, and cross-species integrative omics approaches to understand liver and bile duct cancers at a molecular level. Analysis of Professor Andersen's recent publications reveals a strong focus on cholangiocarcinoma and hepatocellular carcinoma, with research spanning from basic molecular mechanisms to clinical applications. His work increasingly integrates genomic, epigenomic, and immunological approaches to develop precision medicine strategies for liver cancers. Notably, his team has been advancing understanding of tumor heterogeneity, molecular subtypes, and potential therapeutic targets in biliary tract cancers. Scientific Awards: Danish Cancer Society Research Scholarship (2002) AFAR Junior Investigator Award (2007) ISICR Young Investigator Award (2007) Danish Medical Research Council Award (2008) EASL Young Investigator Award (2008) ILCA Investigator Award (2010) Danish Cancer Society "Knæk Cancer" Talented Young Investigator (2014) Novo Nordisk Foundation Hallas-Møller Fellowship (2015) Novo Nordisk Foundation Research Leader Program (2022) Professor Andersen is an active mentor and advisor, having founded and directed BRIC's Postdoc Career Program. He has secured numerous competitive grants from Danish and European funding agencies, including the European Association for the Study of the Liver (EASL) Sheila Sherlock fellowship and multiple Marie Sklodowska-Curie postdoctoral fellowships. His research has been supported by prestigious organizations including the Independent Research Fund Denmark, Danish Cancer Society, and Novo Nordisk Foundation. The Andersen Group operates within the Biotech Research and Innovation Centre (BRIC) at the University of Copenhagen. Professor Andersen has co-founded several international collaborations including the European Network for the Study of Cholangiocarcinoma (ENSCCA), Global Cholangiocarcinoma Alliance, and Precision-BTC network. He serves as an active participant in the Cholangiocarcinoma Foundation USA and member of the International Cholangiocarcinoma Research Network, demonstrating his leadership in creating global research networks focused on rare liver cancers.